etoposide has been researched along with Aging in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 8 (42.11) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, S; Leng, SX; Meng, X; Miao, Y; Tao, Y; Wang, B; Yue, P; Zhang, H | 1 |
| Abou Karam, P; Biran, A; Krizhanovsky, V; Ovadya, Y; Porat, Z; Roitman, L; Vadai, E; Zada, L | 1 |
| Aitken, RJ; McEwan, KE; Mitchell, LA; Scott, RJ; Xavier, MJ | 1 |
| Budovsky, A; Duman, O; Fraifeld, VE; Maor, H; Shteinberg, A; Wolfson, M; Yanai, H | 1 |
| Archer, LE; Damon, LE; Hurd, D; Larson, RA; Linker, CA; Owzar, K; Powell, B | 1 |
| Ballova, V; Diehl, V; Dühmke, E; Eich, HT; Engert, A; Haverkamp, H; Hentrich, M; Josting, A; Löffler, M; Müller-Hermelink, HK; Naumann, R; Pfistner, B; Rüffer, JU; Wilhelmy, M; Worst, P | 1 |
| Büchner, T; Creutzig, U; Döhner, H; Reinhardt, D; Sauerland, MC; Schlenk, RF; Zimmermann, M | 1 |
| Chen, J; Kim, JE; Lou, Z | 1 |
| Beer, M; Cavalli, F; Conter, V; D'Incalci, M; Farina, P; Mangioni, C; Masera, G; Piazza, E; Pisoni, MB; Rocchetti, M; Sessa, C | 1 |
| Ando, M; Eguchi, K; Katsumata, N; Maeda, M; Ohe, Y; Oshita, F; Shinkai, T; Shiraishi, J; Tamura, T; Yamamoto, N | 1 |
| Caporale, R; Cervi, L; Ciolli, S; Giuliani, G; Leoni, F; Pascarella, A; Rossi Ferrini, P; Salti, F | 1 |
| Berthold, F; Boos, J; Euting, T; Jürgens, H; Krümpelmann, S; Schulze-Westhoff, P | 1 |
| Atkins, HL; Curtis, JE; Lipton, JH; Messner, HA; Minden, MD | 1 |
| Matsui, H; Seki, K; Sekiya, S; Takamizawa, H | 1 |
| Fukuda, H; Kunitoh, H; Saijo, N; Sekine, I | 1 |
| Baruchel, S; Chan, H; Fouladi, M; Grant, R; Greenberg, ML; Malkin, D; Weitzman, S | 1 |
| Bernardo, P; Bonomi, P; Cella, D; Johnson, DH; Kugler, JW; Langer, CJ; Manola, J | 1 |
| Howells, DW; Hyland, K; Smith, I; Strobel, S | 1 |
| Aisner, J; Poplin, E; Thompson, B; Whitacre, M | 1 |
2 review(s) available for etoposide and Aging
| Article | Year |
|---|---|
Attenuated-dose idarubicin in acute myeloid leukaemia of the elderly: pharmacokinetic study and clinical results.
Topics: Adult; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid; Male; Middle Aged; Survival Rate | 1995 |
Cancer chemotherapy in the elderly.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Anthraquinones; Antineoplastic Agents; Breast Neoplasms; Busulfan; Daunorubicin; Doxorubicin; Etoposide; Female; Fluorouracil; Heart; Hematologic Neoplasms; Humans; Lung; Male; Middle Aged; Neoplasms; Pyrazoles | 1998 |
4 trial(s) available for etoposide and Aging
| Article | Year |
|---|---|
A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly).
Topics: Administration, Oral; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Infusions, Intravenous; Prednisone; Procarbazine; Prospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 2005 |
Attenuated-dose idarubicin in acute myeloid leukaemia of the elderly: pharmacokinetic study and clinical results.
Topics: Adult; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid; Male; Middle Aged; Survival Rate | 1995 |
Steady-state levels and bone marrow toxicity of etoposide in children and infants: does etoposide require age-dependent dose calculation?
Topics: Adolescent; Aging; Body Surface Area; Body Weight; Bone Marrow Diseases; Child; Child, Preschool; Dose-Response Relationship, Drug; Etoposide; Humans; Individuality; Infant; Infusions, Intravenous; Neuroblastoma | 1995 |
Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial.
Topics: Aged; Aged, 80 and over; Aging; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Paclitaxel; Quality of Life; Random Allocation; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome | 2002 |
14 other study(ies) available for etoposide and Aging
| Article | Year |
|---|---|
The lncRNA MEG3/miR-16-5p/VGLL4 regulatory axis is involved in etoposide-induced senescence of tumor cells.
Topics: A549 Cells; Aging; Apoptosis; beta-Galactosidase; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Etoposide; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HEK293 Cells; Humans; MCF-7 Cells; MicroRNAs; Models, Biological; Neoplasms; RNA, Long Noncoding; Senescence-Associated Secretory Phenotype; Transcription Factors | 2021 |
Quantitative identification of senescent cells in aging and disease.
Topics: Aging; Animals; beta-Galactosidase; Biomarkers; Cellular Senescence; Epithelial Cells; Etoposide; Fibrosis; Flow Cytometry; Gene Expression; Histones; HMGB1 Protein; Humans; Image Processing, Computer-Assisted; Lymphocytes; Mice; Molecular Imaging; Neoplasms; Primary Cell Culture; Single-Cell Analysis; Staining and Labeling; Stromal Cells | 2017 |
Genomic integrity in the male germ line: evidence in support of the disposable soma hypothesis.
Topics: Aging; Animals; Antineoplastic Combined Chemotherapy Protocols; Azoospermia; Bleomycin; Chromatin; Cisplatin; Etoposide; Female; Fertility; Genome; Germ Cells; Male; Mice; Mutation; Pregnancy; Spermatozoa | 2018 |
Uncovering the geroprotective potential of medicinal plants from the Judea region of Israel.
Topics: Aging; Cell Death; Cell Line; Cell Proliferation; Cytokines; Cytoprotection; Dermis; DNA Damage; Etoposide; Fibroblasts; Foreskin; Humans; Inflammation Mediators; Israel; Male; Plant Extracts; Plants, Medicinal; Protective Agents; Time Factors; Wound Healing | 2014 |
Auto-SCT for AML in second remission: CALGB study 9620.
Topics: Adult; Aged; Aging; Antigens, CD34; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Ideal Body Weight; Infusions, Intravenous; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Remission Induction; Transplantation, Autologous; Treatment Outcome; Treatment Refusal; Young Adult | 2009 |
Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.
Topics: Adolescent; Adult; Aging; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow; Child; Child, Preschool; Clinical Trials as Topic; Cytarabine; Etoposide; Female; Humans; Idarubicin; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Prognosis; Risk Factors; Survival Analysis; Treatment Outcome | 2008 |
DBC1 is a negative regulator of SIRT1.
Topics: Adaptor Proteins, Signal Transducing; Aging; Apoptosis; Catalytic Domain; Cell Line; Down-Regulation; Etoposide; Humans; Immunoprecipitation; Leucine Zippers; Mutagens; Protein Binding; Protein Interaction Mapping; Sirtuin 1; Sirtuins | 2008 |
Pharmacokinetics of VP16-213 given by different administration methods.
Topics: Administration, Oral; Adult; Aging; Biological Availability; Child; Etoposide; Humans; Injections, Intravenous; Kinetics; Podophyllotoxin | 1982 |
The influence of ageing on cisplatin pharmacokinetics in lung cancer patients with normal organ function.
Topics: Adult; Aged; Aged, 80 and over; Aging; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Regression Analysis; Vindesine | 1995 |
Intensive remission induction therapy for chronic myeloid leukemia in blast phase with a goal of post-remission bone marrow transplant--a pilot study.
Topics: Adolescent; Adult; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow Transplantation; Etoposide; Female; Fusion Proteins, bcr-abl; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Pilot Projects; Remission Induction; Survival Rate; Vincristine | 1996 |
Reproductive status in GTD treated with etoposide.
Topics: Adult; Aging; Antineoplastic Agents, Phytogenic; Etoposide; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Ovary; Ovulation; Pregnancy; Prolactin; Thyrotropin-Releasing Hormone; Trophoblastic Neoplasms; Uterine Neoplasms | 1997 |
Use of adjuvant ICE chemotherapy in the treatment of anaplastic ependymomas.
Topics: Aging; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Ependymoma; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Survival Analysis | 1998 |
Tryptophan and serotonin metabolism in familial erythrophagocytic lymphohistiocytosis.
Topics: Aging; Amino Acids; Biopterins; Child, Preschool; Etoposide; Histiocytosis, Non-Langerhans-Cell; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant; Male; Methotrexate; Neopterin; Prednisolone; Serotonin; Tryptophan | 1992 |
Small cell carcinoma of the lung: influence of age on treatment outcome.
Topics: Actuarial Analysis; Adult; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Heart Diseases; Hematologic Diseases; Humans; Lung Neoplasms; Middle Aged | 1987 |